0G5N4ZZ
Destruction Inferior Parathyroid Gland, Right to No Qualifier with No Device, Percutaneous Endoscopic Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | G Endocrine System |
| Operation | 5 Destruction |
| Body Part | N Inferior Parathyroid Gland, Right |
| Approach | 4 Percutaneous Endoscopic |
| Device | Z No Device |
| Qualifier | Z No Qualifier |
Operation Definition
Physical eradication of all or a portion of a body part by the direct use of energy, force, or a destructive agent
Procedure Overview
Destruction procedures in the endocrine system eliminate abnormal or diseased tissue in a gland, such as a thyroid nodule, adrenal mass, or pituitary lesion, using energy sources like radiofrequency, laser, cryotherapy, or chemical agents rather than by cutting the tissue out. The gland or the surrounding tissue is not physically removed from the body; it is destroyed in place and the body absorbs or walls off the treated area over time.
This approach is often chosen for patients who are not good candidates for surgical removal, for smaller lesions that do not require full excision, or when preserving as much of the surrounding healthy gland tissue as possible is a priority, such as with certain benign thyroid nodules treated by ablation.
Anatomy & Axis Detail
Inferior Parathyroid Gland, Right
The right inferior parathyroid gland, typically located near the lower pole of the right thyroid lobe or occasionally in a more variable ectopic position due to its thymic embryologic origin, contributes to calcium regulation through parathyroid hormone secretion. Destruction in place is pursued when this specific gland is identified as hyperfunctioning, such as in primary hyperparathyroidism from a solitary adenoma, and ablative treatment like ultrasound-guided ethanol or radiofrequency therapy is selected instead of surgical excision, often for patients with significant operative risk or recurrent disease. Because inferior parathyroid glands have a more variable anatomic position than superior glands, ranging from the thyrothymic ligament down into the mediastinum, preprocedural localization with imaging or nuclear scanning is critical to confirm the correct target before ablation. Documentation must specify the right inferior gland to distinguish it from the superior or contralateral parathyroid glands.
Approach: Percutaneous Endoscopic
Percutaneous Endoscopic combines a puncture through skin or mucous membrane with insertion of an endoscope to visualize the procedure internally, as in laparoscopic cholecystectomy. It is distinguished from plain Percutaneous by the presence of scope-guided visualization, and from Via Natural or Artificial Opening Endoscopic by its route being a new puncture rather than an existing orifice or stoma.
Coding & Documentation
The operative note should describe an energy-based or chemical method used to eradicate tissue in place, with no portion of the gland physically excised or taken out. Coders need to identify the exact energy source and gland involved, since the approach and device values depend on whether an image-guided percutaneous probe, an endoscopic device, or an open technique was used.
The most frequent error is coding Destruction when any portion of tissue was actually cut out and removed for pathology, which instead falls under Excision or Resection. When a biopsy is taken from the same lesion before it is ablated, that sampling should be coded separately as an Excision.